J.W. Cole Advisors Inc. Increases Holdings in GE HealthCare Technologies Inc. $GEHC

J.W. Cole Advisors Inc. grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 312.6% during the 4th quarter, Holdings Channel.com reports. The fund owned 54,884 shares of the company’s stock after acquiring an additional 41,581 shares during the period. J.W. Cole Advisors Inc.’s holdings in GE HealthCare Technologies were worth $4,502,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. Vise Technologies Inc. lifted its holdings in GE HealthCare Technologies by 42.4% in the 4th quarter. Vise Technologies Inc. now owns 7,726 shares of the company’s stock valued at $634,000 after purchasing an additional 2,302 shares in the last quarter. Continuum Advisory LLC purchased a new position in GE HealthCare Technologies in the 4th quarter valued at about $1,253,000. Daiwa Securities Group Inc. boosted its position in GE HealthCare Technologies by 5.2% during the fourth quarter. Daiwa Securities Group Inc. now owns 121,299 shares of the company’s stock worth $9,949,000 after acquiring an additional 5,978 shares during the last quarter. TD Asset Management Inc boosted its position in GE HealthCare Technologies by 2.9% during the fourth quarter. TD Asset Management Inc now owns 388,005 shares of the company’s stock worth $31,824,000 after acquiring an additional 10,962 shares during the last quarter. Finally, Sound Shore Management Inc. CT boosted its position in GE HealthCare Technologies by 3.8% during the fourth quarter. Sound Shore Management Inc. CT now owns 1,017,888 shares of the company’s stock worth $83,487,000 after acquiring an additional 37,132 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $64.67 on Friday. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The company has a market capitalization of $29.42 billion, a price-to-earnings ratio of 15.47, a P/E/G ratio of 1.44 and a beta of 0.74. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The firm has a 50 day moving average of $66.89 and a two-hundred day moving average of $75.49.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business’s revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

Insider Buying and Selling

In other GE HealthCare Technologies news, Director Rodney F. Hochman bought 1,618 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was bought at an average cost of $62.03 per share, with a total value of $100,364.54. Following the completion of the transaction, the director directly owned 1,618 shares of the company’s stock, valued at approximately $100,364.54. The trade was a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Kevin Lobo bought 10,000 shares of the firm’s stock in a transaction on Friday, May 22nd. The stock was acquired at an average cost of $64.18 per share, with a total value of $641,800.00. Following the completion of the transaction, the director directly owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This represents a 229.20% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders purchased 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. BTIG Research decreased their target price on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Citigroup decreased their target price on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research report on Thursday, April 30th. Wells Fargo & Company decreased their target price on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research report on Thursday, April 30th. Oppenheimer restated an “outperform” rating and set a $85.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Finally, Rothschild & Co Redburn decreased their target price on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. Nine investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.21.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.